publication venue for
- Comprehensive review of cardiovascular disease in prostate cancer: epidemiology, risk factors, therapeutics and prevention strategies.. 1-7. 2024
- Cardiovascular risk in ADT recipients: does the type of ADT matter?. 27:435-437. 2024
- Real-world utilization and outcomes of docetaxel among older men with metastatic prostate cancer: a retrospective population-based cohort study in Canada. 26:74-79. 2023
- Overview of seminal fluid biomarkers for the evaluation of chronic prostatitis: a scoping review. 25:627-640. 2022
- Correction: Protective effect of pharmacological castration on metabolic perturbations and cardiovascular disease in the hyperglycemic male ApoE−/−:Ins2+/Akita mouse model. 25:596-596. 2022
- Modifiable risk factors for prostate cancer in low- and lower-middle-income countries: a systematic review and meta-analysis. 25:453-462. 2022
- Protective effect of pharmacological castration on metabolic perturbations and cardiovascular disease in the hyperglycemic male ApoE−/−:Ins2+/Akita mouse model. 24:389-397. 2021
- Cardiac biomarkers in patients with prostate cancer and cardiovascular disease receiving gonadotrophin releasing hormone agonist vs antagonist. 24:177-185. 2021
- Impact of single-agent daily prednisone on outcomes in men with metastatic castration-resistant prostate cancer. 20:67-71. 2017
- Imaging, procedural and clinical variables associated with tumor yield on bone biopsy in metastatic castration-resistant prostate cancer. 17:325-331. 2014
- Erratum: Oxidative stress in prostate cancer: changing research concepts towards a novel paradigm for prevention and therapeutics. 16:398-398. 2013
- Oxidative stress in prostate cancer: changing research concepts towards a novel paradigm for prevention and therapeutics. 16:217-225. 2013
- Adiponectin inhibits oxidative stress in human prostate carcinoma cells. 15:28-35. 2012
- PSA affects prostate cancer cell invasion in vitro and induces an osteoblastic phenotype in bone in vivo. 14:286-294. 2011
- Androgens induce oxidative stress and radiation resistance in prostate cancer cells though NADPH oxidase. 13:39-46. 2010
- Effects of geldanamycin on HIF-1α mediated angiogenesis and invasion in prostate cancer cells. 9:126-135. 2006